TuHURA Biosciences price target lowered to $10 from $12 at H.C. Wainwright

H.C. Wainwright analyst Robert Burns lowered the firm’s price target on TuHURA Biosciences (HURA) to $10 from $12 and keeps a Buy rating on the shares. The firm says the company’s “upcoming value inflection points and recent stock decline provide an attractive entry point.”